Top performing facilities, such as Central Arkansas Radiation Therapy Institute (CARTI), are employing the ExacTrac X-Ray 6D image-guided radiation therapy (IGRT) system, enabling doctors to pinpoint tumors with increased accuracy and treat a wider variety of indications. CARTI treats up to 215 cancer patients weekly with the positioning system and other facilities are reportedly averaging 90 –100 fractions a week, in comparison to 2006 where an average of 65 fractions per week could be administered.

CMS Inc. has completed internal and external validation testing for its new Monaco IMRT planning system. The system, which is CE marked for distribution in Europe, is now pending U.S. FDA 510(k) clearance.

Monaco, according to the company, represents a fundamentally new approach to IMRT planning — the concepts represent a unique and sophisticated set of tools to make the radiotherapy planning process easier, more straightforward and clinically reliable.

Philips Medical Systems recently displayed its Pinnacle3System 810 and Pinnacle3 Web Publishing, two new radiation oncology product offerings designed to increase workflow and operational efficiency, at the American Association of Physicists in Medicine (AAPM) annual meeting in Minneapolis, MN.

At this year’s American Association of Physicists in Medicine (AAPM) annual meeting, Elekta showcased their unique cancer treatment solutions by demonstrating how the joint forces of Elekta and IMPAC Medical Systems help physicians in the fight against cancer.

Recent enhancements to the Varian Medical System’s ARIA Oncology Information System are designed to improve the integration between medical and radiation oncology treatment information and support more flexible data gathering. The electronic medical record (EMR) has been modified so that medical and radiation oncology treatment information appears on the same assessment screens, providing clinicians with a more comprehensive look at a patient’s complete treatment history.

At the AAPM, four abstract presentations focused on Proxcelan with Cesium-131 and its radiobiological characteristics and related dosimetric outcomes in treatment planning.

Proxcelan from IsoRay Medical is the newest isotope used in low dose (LDR) brachytherapy for the treatment of prostate cancer.

The four abstracts included:

1. “Cesium-131 Prostate Brachytherapy and Treatment Plan Parameters”
Authors: Sutlief, S. & Wallner, K

Acceletronics Inc. announced that it has recently completed the installation of 15 TheraView Electronic Portal Imaging Devices (EPID) over the past six months to 11 cancer treatment centers in the U.S. The TheraView EPID is an image-guided radiotherapy (IGRT) cancer treatment verification system designed by Dutch manufacturer Cablon Medical BV.

Now users of MIMvista Corp.’s MIMcontouring software can simultaneously fuse multiple modalities with the planning CT allowing contours to be created on any fused image. Contours created on one image apply to all images.True 3D contouring allows users to create and edit contours in any plane on any image.

Using innovative physics, researchers have proposed a system that may one day bring proton therapy, a state-of-the-art cancer treatment method currently available only at a handful of centers, to radiation treatment centers and cancer patients everywhere. Compared to the X-rays conventionally used in radiation therapy, protons are potentially more effective, as they can deposit more cell-killing energy in their tumor targets and less in surrounding healthy tissue.

Global Dosimetry Solutions Inc., a division of Mirion Technologies, announced the release of a copper doped quartz fiber in vivo dosimeter, which provides real-time assessment of tissue exposure to radiation during radiodiagnostic and radiotherapeutic procedures, as part of its strategy to provide solutions for radiation therapy and diagnostic radiology.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now